![Niamh O'Luanaigh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Niamh O'Luanaigh
Direttore operativo presso Biosensia Ltd.
Profilo
Niamh O'Luanaigh is currently the Chief Operating Officer at Biosensia Ltd.
She previously worked as a Principal at BBI Diagnostics Group Ltd.
Dr. O'Luanaigh has an undergraduate degree from the University Of Dundee and a doctorate degree from University College London.
Posizioni attive di Niamh O'Luanaigh
Società | Posizione | Inizio |
---|---|---|
Biosensia Ltd.
![]() Biosensia Ltd. Packaged SoftwareTechnology Services Biosensia Ltd. develops multiplexing point of care in vitro diagnostics platform. It offers RapiPlex, a point-of-care diagnosis system based on a set of proprietary technologies capable of producing quantitative and qualitative laboratory quality test results. The company was founded by Gareth Redmond and Gabriel Crean in 2009 and is headquartered in Dublin, Ireland. | Direttore operativo | 15/03/2013 |
Precedenti posizioni note di Niamh O'Luanaigh
Società | Posizione | Fine |
---|---|---|
BBI Diagnostics Group Ltd.
![]() BBI Diagnostics Group Ltd. Medical SpecialtiesHealth Technology BBI Diagnostics Group Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. The firm’s products include cell culture reagents, conjugates, depleted serum, disease state plasma, enzymes, finished kits, gold nanoparticles, monoclonal antibodies, normal serums, patient samples, polyclonal antibodies, recombinant antibodies, silver nanoparticles, biothreat and explosives antibodies. It’s services include custom conjugation, lateral flow assay development, 3DNA pushing assay sensitivity to the limit, test optimisation, atomo rapid platform and the novarum reader. The company was founded by John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom. | Corporate Officer/Principal | - |
Formazione di Niamh O'Luanaigh
University Of Dundee | Undergraduate Degree |
University College London | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Biosensia Ltd.
![]() Biosensia Ltd. Packaged SoftwareTechnology Services Biosensia Ltd. develops multiplexing point of care in vitro diagnostics platform. It offers RapiPlex, a point-of-care diagnosis system based on a set of proprietary technologies capable of producing quantitative and qualitative laboratory quality test results. The company was founded by Gareth Redmond and Gabriel Crean in 2009 and is headquartered in Dublin, Ireland. | Technology Services |
BBI Diagnostics Group Ltd.
![]() BBI Diagnostics Group Ltd. Medical SpecialtiesHealth Technology BBI Diagnostics Group Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. The firm’s products include cell culture reagents, conjugates, depleted serum, disease state plasma, enzymes, finished kits, gold nanoparticles, monoclonal antibodies, normal serums, patient samples, polyclonal antibodies, recombinant antibodies, silver nanoparticles, biothreat and explosives antibodies. It’s services include custom conjugation, lateral flow assay development, 3DNA pushing assay sensitivity to the limit, test optimisation, atomo rapid platform and the novarum reader. The company was founded by John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Niamh O'Luanaigh